- Study: What is the risk for contralateral breast cancer in women with an inherited BRCA1, BRCA2 or TP53 mutation?
- [No author given]
- FORCE. XRAYS. 2020 Jun 6.
- Research news
- Free Full Text
Original research:
Risk of Contralateral Breast Cancer in Women with and without Pathogenic Variants in BRCA1, BRCA2, and TP53 Genes in Women with Very Early-Onset (<36 Years) Breast Cancer.
- PMID: 32045981
- PubMed abstract
- Free Full Text
- Germline Results From Tumor-Normal Sequencing Guides Precision Therapy in Advanced Cancer Patients.
- Ray T.
- Precision Oncology News. 2020 May 31.
- Conference news, Research news
- Free Full Text
Guidelines:
Points to consider for reporting of germline variation in patients undergoing tumor testing: a statement of the American College of Medical Genetics and Genomics (ACMG).
- PMID: 32321997
- PubMed abstract
- Free Full Text